Johnson & Johnson Vision Care
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johnson & Johnson Vision Care sits in the top decile of US sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count).
Johnson & Johnson Vision Care: 142 sponsored US clinical trials, 1 recruiting.
Johnson & Johnson Vision Care sponsors 142 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 139 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Visual Acuity, with 19 trials.
Top-decile sponsor footprint
Johnson & Johnson Vision Care ranks in the top decile of sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
139 of 141 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
142 total, page 2 of 3
Evaluation of Visual Performance of Two Types of Cosmetic Contact Lenses
NCT04534764
Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population
NCT04310566
Objective Vision Evaluation of Two Cosmetic Contact Lenses
NCT04287036
Evaluation of a Reusable Silicone Hydrogel Multifocal Contact Lens
NCT04189224
Comparison of Two Silicone Hydrogel Multifocal Contact Lenses
NCT04093258
Evaluation of A Marketed Silicone Hydrogel Spherical Lens Used for Monovision Correction of Presbyopia
NCT04073186
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology
NCT03962790
Ocular Characteristics in Contact Lens and Spectacle Wear
NCT03913377
Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population
NCT03787472
MiBo ThermoFlo Lid Temperature Evaluation
NCT03787212
Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control
NCT03635528
Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population
NCT03742271
Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
NCT03713281
Design Validation of Senofilcon A With New UV-blocking Additive
NCT03707821
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
NCT03701516
Initial Evaluation of Investigational Lenses Manufactured on a New Production Line
NCT03679741
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process
NCT03605303
Contact Lens Insertion and Removal in a Senior Subject Demographic
NCT03597178
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
NCT03586648
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population
NCT03581825
The Effects of Contact Lenses With Experimental Dye on Visual Function
NCT03556579
Contact Lenses With New UV-blocker Manufactured With Different Techniques
NCT03475875
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types
NCT03466060
Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid Style
NCT03431441
Clinical Evaluation of Etafilcon A With Ketotifen
NCT03388138
Clinical Characterization of Symptomatic Populations
NCT03319212
Evaluation of Two Marketed Multifocal Contact Lenses
NCT03322423
Evaluation of Approved and Investigational Contact Lenses
NCT03228212
Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers
NCT03222037
Clinical Evaluation of Multifocal Toric Contact Lenses
NCT03208088
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2
NCT03168542
Clinical Evaluation of Fitting Investigational Contact Lenses
NCT03150485
Evaluation of Astigmatic Contact Lenses
NCT03086447
Clinical Evaluation of Investigational Multifocal Contact Lenses
NCT03059810
Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV Additive
NCT02982018
Clinical Evaluation of Two Approved Contact Lenses
NCT02759692
Clinical Evaluation of Approved Contact Lenses
NCT02699593
Clinical Study of Approved and Investigational Contact Lenses
NCT02708524
Clinical Evaluation of Approved and Investigational Contact Lenses
NCT02669095
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses
NCT02625233
Dispensing Evaluation of Investigational Contact Lenses
NCT02625220
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses
NCT02595502
Pilot Clinical Evaluation of Approved Contact Lenses
NCT02540122
Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact Lenses
NCT02537522
Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens
NCT02515994
A Comparison of Two Daily Disposable Soft Contact Lenses
NCT02427477
Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes
NCT02394925
Handling Comparison Between Two Contact Lens Types
NCT02310126
Central Corneal Swelling With Silicone Hydrogel Materials
NCT02328937
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Johnson & Johnson Vision Care pipeline
1 recruiting of 142 indexed (1% open); 139 completed (98%).
Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Visual Acuity (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johnson & Johnson Vision Care: open-pipeline peers nationwide
Peers matched on 142 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
Johnson & Johnson Vision Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 142 trials (± recruiting share)
- Case Western Reserve University · 141 trials · 16% recruiting
- Eastern Cooperative Oncology Group · 141 trials · 3% recruiting
- Purdue University · 141 trials · 10% recruiting
- Radiation Therapy Oncology Group · 144 trials · 0% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Mylan Pharmaceuticals · 1% recruiting · 146 trials
- Gynecologic Oncology Group · 1% recruiting · 154 trials
- Shire · 0% recruiting · 245 trials
- Abbott Nutrition · 1% recruiting · 89 trials
Related
What to do with this Johnson & Johnson Vision Care page
142 registered trials is a research-attention snapshot, not an endorsement of Johnson & Johnson Vision Care or any single study.
- 1 of Johnson & Johnson Vision Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Visual Acuity is the condition Johnson & Johnson Vision Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Visual Acuity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Johnson & Johnson Vision Care pipeline card: 142 registered trials from official public datasets.Report a data error.